Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for LAB

Stock NameStandard Biotools Inc
TickerLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS34385P1084
LEI549300GX8Y96GSB6YP89

Show aggregate LAB holdings

News associated with LAB

Critical Survey: Standard BioTools (NASDAQ:LAB) & P3 Health Partners (NASDAQ:PIII)
Standard BioTools (NASDAQ:LAB – Get Free Report) and P3 Health Partners (NASDAQ:PIII – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Volatility and Risk Standard BioTools has […] - 2025-08-18 05:46:52
Standard BioTools (NASDAQ:LAB) Raised to “Hold” at Wall Street Zen
Standard BioTools (NASDAQ:LAB – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday. LAB has been the topic of a number of other reports. Cowen cut shares of Standard BioTools from a “buy” rating to a […] - 2025-08-18 04:46:56
XTX Topco Ltd Purchases New Holdings in Standard BioTools Inc. (NASDAQ:LAB)
XTX Topco Ltd purchased a new stake in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) in the first quarter, Holdings Channel reports. The firm purchased 158,087 shares of the company’s stock, valued at approximately $171,000. A number of other institutional investors and hedge funds also recently modified their holdings of the business. Oppenheimer […] - 2025-08-14 04:25:02
Standard BioTools Inc. (NASDAQ:LAB) Stock Holdings Decreased by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lessened its holdings in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 5.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,233,693 shares of the company’s stock after selling 384,701 shares during the period. […] - 2025-07-04 05:10:58
California State Teachers Retirement System Sells 18,285 Shares of Standard BioTools Inc. (NASDAQ:LAB)
California State Teachers Retirement System decreased its holdings in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The firm owned 213,266 shares of the company’s stock after selling 18,285 shares during the quarter. California State Teachers Retirement System’s holdings in Standard BioTools were worth $373,000 at the end […] - 2025-06-12 04:52:48
Wells Fargo & Company MN Acquires 40,894 Shares of Standard BioTools Inc. (NASDAQ:LAB)
Wells Fargo & Company MN lifted its stake in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 29.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 181,256 shares of the company’s stock after buying an additional 40,894 shares during […] - 2025-05-06 04:18:54
Invesco Ltd. Grows Position in Standard BioTools Inc. (NASDAQ:LAB)
Invesco Ltd. boosted its position in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 7.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 175,041 shares of the company’s stock after acquiring an additional 12,194 shares during the quarter. Invesco Ltd.’s holdings in Standard BioTools were worth $306,000 at the end of the […] - 2025-05-05 04:38:52
Rockefeller Capital Management L.P. Grows Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB)
Rockefeller Capital Management L.P. grew its holdings in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 83.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 296,631 shares of the company’s stock after acquiring an additional 135,075 shares during the period. Rockefeller […] - 2025-04-24 05:56:54
Commonwealth Equity Services LLC Sells 51,993 Shares of Standard BioTools Inc. (NASDAQ:LAB)
Commonwealth Equity Services LLC lowered its stake in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 31.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 113,000 shares of the company’s stock after selling 51,993 shares during the period. Commonwealth Equity Services LLC’s holdings in Standard BioTools were worth $198,000 as of its most […] - 2025-04-11 04:30:44
Cibc World Markets Corp Invests $48,000 in Standard BioTools Inc. (NASDAQ:LAB)
Cibc World Markets Corp purchased a new stake in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 27,606 shares of the company’s stock, valued at approximately $48,000. A number of other large investors have also added to or reduced their stakes in LAB. Hollow Brook […] - 2025-03-28 06:18:48
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its stake in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 30.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,618,394 shares of the company’s stock after selling 2,960,169 shares during the period. Sumitomo Mitsui […] - 2025-02-13 07:28:55

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc LAB holdings

DateNumber of LAB Shares HeldBase Market Value of LAB SharesLocal Market Value of LAB SharesChange in LAB Shares HeldChange in LAB Base ValueCurrent Price per LAB Share HeldPrevious Price per LAB Share Held
2025-09-29 (Monday)233,395USD 296,412USD 296,412
2025-09-26 (Friday)233,395USD 303,414USD 303,414
2025-09-25 (Thursday)233,395USD 301,080LAB holding decreased by -4667USD 301,0800USD -4,667 USD 1.29 USD 1.31
2025-09-24 (Wednesday)233,395USD 305,747USD 305,747
2025-09-17 (Wednesday)231,877USD 313,034LAB holding decreased by -6956USD 313,0340USD -6,956 USD 1.35 USD 1.38
2025-09-16 (Tuesday)231,877USD 319,990USD 319,990
2025-09-12 (Friday)230,359USD 297,163USD 297,163
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LAB by Blackrock for IE00B3VWM098

Show aggregate share trades of LAB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY3,034 1.330* 1.34
2025-08-21SELL-758 1.200* 1.34 Profit of 1,015 on sale
2025-07-31BUY2,271 1.330* 1.34
2025-07-07BUY70,084 1.280* 1.34
2025-06-30SELL-1,020 1.200* 1.34 Profit of 1,368 on sale
2025-06-25SELL-510 1.250* 1.34 Profit of 685 on sale
2025-06-20SELL-1,020 1.050* 1.35 Profit of 1,375 on sale
2025-05-30BUY110,075 1.010* 1.38
2025-05-23BUY129 0.922* 1.40
2025-05-19SELL-129 1.050* 1.41 Profit of 182 on sale
2025-05-15SELL-387 1.050* 1.42 Profit of 548 on sale
2025-05-12SELL-129 1.160* 1.42 Profit of 184 on sale
2025-05-09SELL-129 1.070* 1.43 Profit of 184 on sale
2025-04-30SELL-129 1.110* 1.45 Profit of 187 on sale
2025-04-24SELL-258 1.230* 1.46 Profit of 376 on sale
2025-04-17SELL-129 1.160* 1.47 Profit of 190 on sale
2025-04-15SELL-387 1.150* 1.48 Profit of 573 on sale
2025-04-14SELL-387 1.150* 1.48 Profit of 574 on sale
2025-04-09SELL-516 1.160* 1.50 Profit of 771 on sale
2025-04-07SELL-910 1.100* 1.51 Profit of 1,370 on sale
2025-04-04SELL-1,300 1.070* 1.51 Profit of 1,963 on sale
2025-03-31BUY130 1.080* 1.52
2025-03-19SELL-260 1.180* 1.56 Profit of 406 on sale
2025-03-14SELL-780 1.140* 1.58 Profit of 1,232 on sale
2025-03-13SELL-260 1.100* 1.59 Profit of 412 on sale
2025-03-12SELL-4,420 1.150* 1.59 Profit of 7,038 on sale
2025-03-07SELL-260 1.160* 1.61 Profit of 419 on sale
2025-03-06SELL-390 1.130* 1.62 Profit of 632 on sale
2025-03-03SELL-130 1.010* 1.65 Profit of 214 on sale
2025-02-28SELL-780 1.065* 1.66 Profit of 1,291 on sale
2025-02-26SELL-130 1.170* 1.67 Profit of 218 on sale
2025-02-25SELL-390 1.260* 1.68 Profit of 655 on sale
2025-02-18BUY650 1.400* 1.72
2025-02-13BUY130 1.330* 1.74
2025-02-12BUY130 1.355* 1.74
2025-02-11BUY390 1.305* 1.75
2025-02-06BUY1,170 1.420* 1.78
2025-01-27BUY130 1.570* 1.83
2024-12-30BUY650 1.770* 1.84
2024-12-06BUY520 1.820* 1.84
2024-12-05BUY130 1.760* 1.84
2024-12-04BUY650 1.850* 1.84
2024-11-29BUY650 1.840* 1.83
2024-11-27BUY520 1.820* 1.84
2024-11-26BUY130 1.710* 1.84
2024-11-21BUY650 1.620* 1.88
2024-11-20BUY390 1.610* 1.89
2024-11-18BUY1,555 1.500* 1.94
2024-11-12BUY1,032 2.050* 1.93
2024-11-08BUY645 2.150* 1.92
2024-11-07BUY1,935 2.180* 1.90
2024-11-06BUY258 2.260* 1.87
2024-10-31BUY129 1.960* 1.78
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LAB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19251,5900706,48035.6%
2025-09-18117,423600293,65440.0%
2025-09-17151,1470287,05452.7%
2025-09-16107,4320322,07533.4%
2025-09-15413,2970717,60457.6%
2025-09-1299,1820364,75127.2%
2025-09-11120,5392,018299,46640.3%
2025-09-10244,7940287,79385.1%
2025-09-09173,69125303,05557.3%
2025-09-08383,25412,2181,227,93731.2%
2025-09-05151,1195598,42925.3%
2025-09-04160,5560373,75043.0%
2025-09-03229,19210490,35346.7%
2025-09-02137,4660306,09244.9%
2025-08-2985,2370221,44638.5%
2025-08-2899,2230272,98336.3%
2025-08-27222,747800687,53932.4%
2025-08-2687,9890299,84429.3%
2025-08-25112,752950448,71525.1%
2025-08-22120,21649723,24416.6%
2025-08-2179,6520328,52824.2%
2025-08-2090,9100483,66118.8%
2025-08-1997,10293257,04137.8%
2025-08-18231,4474,600615,35137.6%
2025-08-15125,47344,078351,84635.7%
2025-08-14293,56817,229803,83936.5%
2025-08-13360,8671,495732,30449.3%
2025-08-12151,6780362,31641.9%
2025-08-11337,1660514,67965.5%
2025-08-08146,10822844,00017.3%
2025-08-07107,0390192,75955.5%
2025-08-0690,9510172,96252.6%
2025-08-0552,298082,87463.1%
2025-08-04103,8730781,66013.3%
2025-08-01241,7922,209445,36854.3%
2025-07-31216,7030465,13446.6%
2025-07-30276,8590464,40559.6%
2025-07-29204,2160368,99855.3%
2025-07-28118,586213313,25137.9%
2025-07-25128,8210537,18224.0%
2025-07-24282,0180621,25745.4%
2025-07-23389,6262,2001,315,86029.6%
2025-07-22220,080727756,23129.1%
2025-07-21371,8630536,25169.3%
2025-07-18444,2970636,28069.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.